These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23499033)

  • 1. Screening for type 2 diabetes and population mortality over 10 years.
    Nwaneri C; Bowen-Jones D; Cooper H
    Lancet; 2013 Mar; 381(9870):901-2. PubMed ID: 23499033
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for type 2 diabetes and population mortality over 10 years.
    Lauritzen T; Borch-Johnsen K
    Lancet; 2013 Mar; 381(9870):902. PubMed ID: 23499035
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for type 2 diabetes and population mortality over 10 years.
    Donzelli A
    Lancet; 2013 Mar; 381(9870):902-3. PubMed ID: 23499034
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for type 2 diabetes does not reduce mortality over 10 years.
    Adriaanse MC; Pouwer F
    Evid Based Med; 2013 Oct; 18(5):e44. PubMed ID: 23435254
    [No Abstract]   [Full Text] [Related]  

  • 5. Tackling the global diabetes burden: will screening help?
    Engelgau MM; Gregg EW
    Lancet; 2012 Nov; 380(9855):1716-8. PubMed ID: 23040423
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for type 2 diabetes and population mortality over 10 years - authors' reply.
    Griffin SJ; Simmons RK; Sharp SJ;
    Lancet; 2013 Mar; 381(9870):903. PubMed ID: 23499036
    [No Abstract]   [Full Text] [Related]  

  • 7. Most screening tests do not save lives, researchers argue.
    Wise J
    BMJ; 2015 Jan; 350():h250. PubMed ID: 25592316
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary: Tempering expectations of screening: what is the most authoritative advice we can give, given the data that we have?
    Taylor P
    Int J Epidemiol; 2015 Feb; 44(1):280-2. PubMed ID: 25596212
    [No Abstract]   [Full Text] [Related]  

  • 9. [General health checks and diabetes screening has no effect].
    Krogsbøll LT; Jørgensen KJ; Gøtzsche PC
    Ugeskr Laeger; 2012 Dec; 174(50):3203; author reply 3200. PubMed ID: 23373075
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on N Saquib et al. Does screening for disease save lives in asymptomatic adults? Systematic review of 5 meta-analyses and randomized trials.
    Shekelle PG
    Int J Epidemiol; 2015 Feb; 44(1):277-8. PubMed ID: 25596214
    [No Abstract]   [Full Text] [Related]  

  • 11. Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials.
    Saquib N; Saquib J; Ioannidis JP
    Int J Epidemiol; 2015 Feb; 44(1):264-77. PubMed ID: 25596211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of cardiovascular mortality in type-2 diabetes by aggressive and early intervention strategies.
    Schernthaner G
    Wien Klin Wochenschr; 1999 Jan; 111(2):43-5. PubMed ID: 10081120
    [No Abstract]   [Full Text] [Related]  

  • 13. Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cluster-randomised controlled trial.
    Simmons RK; Bruun NH; Witte DR; Borch-Johnsen K; Jørgensen ME; Sandbæk A; Lauritzen T
    Diabetologia; 2017 Jun; 60(6):1016-1021. PubMed ID: 28280901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland.
    Barnett KN; Ogston SA; McMurdo ME; Morris AD; Evans JM
    Diabet Med; 2010 Oct; 27(10):1124-9. PubMed ID: 20854379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body weight and mortality in type 2 diabetes: weighing up the evidence.
    Logue J; Sattar N
    Diabetes Metab; 2013 Sep; 39(4):287-8. PubMed ID: 23928206
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetes Infobus 1999. Blood pressure].
    Ecker J
    Acta Med Austriaca Suppl; 2002; 56():12-3. PubMed ID: 12436706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported diabetes and mortality in a prospective Chinese elderly cohort study in Hong Kong.
    Shen C; Schooling CM; Chan WM; Lee SY; Leung GM; Lam TH
    Prev Med; 2014 Jul; 64():20-6. PubMed ID: 24704132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors.
    Cea Soriano L; Johansson S; Stefansson B; Rodríguez LA
    Cardiovasc Diabetol; 2015 Apr; 14():38. PubMed ID: 25909295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up.
    Svendstrup M; Christiansen MS; Magid E; Hommel E; Feldt-Rasmussen B
    J Diabetes Complications; 2013; 27(6):570-5. PubMed ID: 23932410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46).
    Riphagen IJ; Logtenberg SJ; Groenier KH; van Hateren KJ; Landman GW; Struck J; Navis G; Kootstra-Ros JE; Kema IP; Bilo HJ; Kleefstra N; Bakker SJ
    Atherosclerosis; 2015 Sep; 242(1):179-85. PubMed ID: 26201002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.